Cargando…
The Long and Short of Tamoxifen Therapy: A Review of the ATLAS Trial
Review of "Long term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial" by Davies et al. (2013), Lancet, 381, 805–816. For another perspective on the ATLAS trial, please se...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Harborside Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4093467/ https://www.ncbi.nlm.nih.gov/pubmed/25032035 |
_version_ | 1782325735391756288 |
---|---|
author | Smith, G. Lita |
author_facet | Smith, G. Lita |
author_sort | Smith, G. Lita |
collection | PubMed |
description | Review of "Long term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial" by Davies et al. (2013), Lancet, 381, 805–816. For another perspective on the ATLAS trial, please see the article on randomization and adjusting for covariates by Dustin Dickerson starting on page 61. |
format | Online Article Text |
id | pubmed-4093467 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Harborside Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-40934672014-07-16 The Long and Short of Tamoxifen Therapy: A Review of the ATLAS Trial Smith, G. Lita J Adv Pract Oncol Review Article Review of "Long term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial" by Davies et al. (2013), Lancet, 381, 805–816. For another perspective on the ATLAS trial, please see the article on randomization and adjusting for covariates by Dustin Dickerson starting on page 61. Harborside Press 2014 2014-01-01 /pmc/articles/PMC4093467/ /pubmed/25032035 Text en Copyright © 2014, Harborside Press http://creativecommons.org/licenses/by/2.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited and is for non-commercial purposes. |
spellingShingle | Review Article Smith, G. Lita The Long and Short of Tamoxifen Therapy: A Review of the ATLAS Trial |
title | The Long and Short of Tamoxifen Therapy: A Review of the ATLAS Trial |
title_full | The Long and Short of Tamoxifen Therapy: A Review of the ATLAS Trial |
title_fullStr | The Long and Short of Tamoxifen Therapy: A Review of the ATLAS Trial |
title_full_unstemmed | The Long and Short of Tamoxifen Therapy: A Review of the ATLAS Trial |
title_short | The Long and Short of Tamoxifen Therapy: A Review of the ATLAS Trial |
title_sort | long and short of tamoxifen therapy: a review of the atlas trial |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4093467/ https://www.ncbi.nlm.nih.gov/pubmed/25032035 |
work_keys_str_mv | AT smithglita thelongandshortoftamoxifentherapyareviewoftheatlastrial AT smithglita longandshortoftamoxifentherapyareviewoftheatlastrial |